Saluda Medical receives $10 million in Series B financing: Dr John Parker, CEO of Saluda Medical was here at HealthTech Sydney on the 2nd of December 2014. He talked about a variety of topics from Intro to the medical devices industry, pain management, commercialisation, funding and about his role as a CEO. Today Saluda medical received a $10 million investment from Biosciences Managers. This puts Saluda one step closer to their goal. Saluda intends to use the funds to conduct chronic clinical trials and support commercialization plans for its Evoke™ spinal cord stimulation system to treat chronic pain of the trunk and limbs.